Global Proton Pump Inhibitors Market To Be Driven By Rise In The Prevalence Of Gastroin****inal Disorders In The Forecast Period Of 2022-2027
Proton pump inhibitors (PPIs) are a class of medications that function by inhibiting the generation of acid in the stomach’s lining cells. They are marketed under numerous brand names and include esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole.
https://www.expertmarketresear....ch.com/reports/proto
Like
Comment
Share
